Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC.

IF 4.6 2区 医学 Q2 IMMUNOLOGY
Qian Si, Yuhan Wang, Wanqiu Lu, Zijian Liu, Yuxian Song, Sheng Chen, Shu Xia, Huiling Li, Pei Weng, Yue Jing, Qiuya Yu, Feng Zhu, Xiaoxin Zhang, Xiaofeng Huang, Yanhong Ni
{"title":"Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC.","authors":"Qian Si, Yuhan Wang, Wanqiu Lu, Zijian Liu, Yuxian Song, Sheng Chen, Shu Xia, Huiling Li, Pei Weng, Yue Jing, Qiuya Yu, Feng Zhu, Xiaoxin Zhang, Xiaofeng Huang, Yanhong Ni","doi":"10.1007/s00262-024-03894-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Transferrin receptor (TFRC) uptakes iron-loaded transferrin (TF) to acquire iron and regulates tumor development. Nonetheless, the clinical values and the precise functions of TF-TFRC axis in the development of oral squamous cell carcinoma (OSCC) were still undiscovered, especially the impacts of their regional heterogeneous expression.</p><p><strong>Methods: </strong>Immunohistochemistry (IHC) was used to analyze the expression of TFRC in 106 OSCC patients. Then the prognostic value of TFRC was compared between high and low worst pattern of invasion (WPOI) patients. OSCC cells with low or high expression of TFRC were constructed, and functional experiments were performed to elucidate the effects of TFRC on the migration and proliferation of OSCC cells. Multi-immunofluorescence was applied to stain TF and tumor-associated neutrophils (TANs). The stimulating effects of TF were compared between normal and high TFRC cells in vitro and across different OSCC patients' subgroups in our sample bank and TCGA database.</p><p><strong>Results: </strong>Higher TFRC was expressed at invasive tumor front (ITF) in OSCC and correlated with WPOI. Only at ITF in patients with WPOI 4-5, TFRC was a prognostic factor. High TFRC promoted migration and proliferation of cancer cells. Additionally, TANs secreted TF outside. Exogenous TF promoted migration and proliferation of cells with high expression of TFRC. Compared to the TANs<sup>low</sup>TFRC<sup>low</sup> OSCC patients, TANs<sup>high</sup>TFRC<sup>high</sup> OSCC patients had poorer clinical outcomes.</p><p><strong>Conclusions: </strong>Higher expression of TFRC at ITF and TANs-TF-TFRC axis promoted OSCC invasion at ITF by facilitating cell migration and proliferation, which may result from increased cellular iron uptake through regulating iron metabolism.</p>","PeriodicalId":9595,"journal":{"name":"Cancer Immunology, Immunotherapy","volume":"74 2","pages":"43"},"PeriodicalIF":4.6000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699170/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Immunology, Immunotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00262-024-03894-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Transferrin receptor (TFRC) uptakes iron-loaded transferrin (TF) to acquire iron and regulates tumor development. Nonetheless, the clinical values and the precise functions of TF-TFRC axis in the development of oral squamous cell carcinoma (OSCC) were still undiscovered, especially the impacts of their regional heterogeneous expression.

Methods: Immunohistochemistry (IHC) was used to analyze the expression of TFRC in 106 OSCC patients. Then the prognostic value of TFRC was compared between high and low worst pattern of invasion (WPOI) patients. OSCC cells with low or high expression of TFRC were constructed, and functional experiments were performed to elucidate the effects of TFRC on the migration and proliferation of OSCC cells. Multi-immunofluorescence was applied to stain TF and tumor-associated neutrophils (TANs). The stimulating effects of TF were compared between normal and high TFRC cells in vitro and across different OSCC patients' subgroups in our sample bank and TCGA database.

Results: Higher TFRC was expressed at invasive tumor front (ITF) in OSCC and correlated with WPOI. Only at ITF in patients with WPOI 4-5, TFRC was a prognostic factor. High TFRC promoted migration and proliferation of cancer cells. Additionally, TANs secreted TF outside. Exogenous TF promoted migration and proliferation of cells with high expression of TFRC. Compared to the TANslowTFRClow OSCC patients, TANshighTFRChigh OSCC patients had poorer clinical outcomes.

Conclusions: Higher expression of TFRC at ITF and TANs-TF-TFRC axis promoted OSCC invasion at ITF by facilitating cell migration and proliferation, which may result from increased cellular iron uptake through regulating iron metabolism.

转铁蛋白受体从肿瘤相关的中性粒细胞中摄取铁来调节OSCC的侵袭模式。
背景:转铁蛋白受体(TFRC)通过铁负载转铁蛋白(TF)获取铁并调节肿瘤的发展。然而,TF-TFRC轴在口腔鳞状细胞癌(OSCC)发展中的临床价值和确切功能,特别是其区域异质性表达的影响尚不清楚。方法:应用免疫组化(IHC)方法分析106例OSCC患者TFRC的表达。然后比较TFRC在高、低最差浸润模式(WPOI)患者的预后价值。构建TFRC低表达和高表达的OSCC细胞,通过功能实验研究TFRC对OSCC细胞迁移和增殖的影响。应用多重免疫荧光染色TF和肿瘤相关中性粒细胞(TANs)。比较了TF在体外正常细胞和高TFRC细胞之间的刺激作用,以及我们的样本库和TCGA数据库中不同OSCC患者亚组的刺激作用。结果:OSCC侵袭性肿瘤前缘(invasive tumor front, ITF)表达较高的TFRC,与WPOI相关。只有在WPOI 4-5患者的ITF时,TFRC是一个预后因素。高TFRC促进癌细胞的迁移和增殖。此外,TANs在外部分泌TF。外源性TF促进TFRC高表达细胞的迁移和增殖。与TANslowTFRClow的OSCC患者相比,tansightfrcigh的OSCC患者临床预后较差。结论:TFRC在ITF和TANs-TF-TFRC轴的高表达促进了OSCC在ITF的侵袭,促进了细胞的迁移和增殖,这可能是通过调节铁代谢增加细胞对铁的摄取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.50
自引率
1.70%
发文量
207
审稿时长
1 months
期刊介绍: Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. As knowledge expands, the scope of the journal has broadened to include more of the progress being made in the areas of biology concerned with biological response modifiers. This helps keep readers up to date on the latest advances in our understanding of tumor-host interactions. The journal publishes short editorials including "position papers," general reviews, original articles, and short communications, providing a forum for the most current experimental and clinical advances in tumor immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信